[ET Net News Agency, 1 November 2023] EVEREST MED-B (01952) rose 10.1% to HK$30.6.
It hits an intra-day high of HK$30.6, hitting a 52-week high, and an intra-day low of
HK$27.35. The total shares traded was 4.91 million, with a value of HK$142.54m. The active
buy/sell ratio is 70:30, with net buying turnover of HK$55.9m. CHINA SEC INT'L BRO
accounts for greatest net responsive buying turnover of HK$1.25m, with volume weighted
average price of HK$30.156. CITIGROUP GLOBAL accounts for greatest net responsive selling
turnover of HK$10m, with volume weighted average price of HK$28.747.
Basic Information
=================
----------------------------------
Nominal 30.600 % Chg +10.07%
High 30.600 Low 27.350
Shares Tr 4.91m Turnover 142.54m
10-D SMA 25.505 %H.V 85.779
20-D SMA 25.452 VWAP 29.001
50-D SMA 21.758 RSI14 70.275
----------------------------------
Status: Hitting a 52-week high, active buy/sell ratio is 70:30, with net buying turnover
of HK$55.9m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
EVEREST MED-B (01952) 30.60 +10.07
GENSCRIPT BIO (01548) 23.20 +2.20
INNOVENT BIO (01801) 46.05 Unchanged
JXR (01951) 3.94 +0.25
WUXI BIO (02269) 48.05 -1.13
WUXI APPTEC (02359) 92.30 -1.81
BEIGENE (06160) 112.40 -0.79
ASCENTAGE-B (06855) 26.20 +3.15
ZAI LAB (09688) 19.70 -0.71
AKESO (09926) 44.45 +1.25
---------------------------------------------
(ed)